### Assessment of Compliance with HIPAA Privacy Rule

1. **Check the HIPAA regulation IDs (164.502(a)(5)(ii)(B)(2)(iii)) and their content:**
   - The HIPAA regulation IDs 164.502(a)(5)(ii)(B)(2)(iii) pertain to the permitted uses and disclosures for judicial and administrative proceedings. These regulations outline the circumstances under which protected health information (PHI) can be disclosed for legal purposes.

2. **Determine whether the HIPAA Privacy Rule permits or forbids the case:**
   - The HIPAA Privacy Rule, under 45 C.F.R. ยง 164.512(e)(1)(iii) and 45 C.F.R. ยง 164.514(b)(2), allows for the disclosure of PHI for litigation purposes under certain conditions, such as ensuring appropriate safeguards are in place to protect the privacy of individuals.
   
3. **Answer: Permit or Forbid:**
   - In this case involving Eli Lilly & Company and the state governments seeking Medicaid patients' medical records for legal proceedings related to Zyprexa, the HIPAA Privacy Rule permits the disclosure of medical information for litigation purposes, provided that the appropriate safeguards and criteria are met.
   
   Therefore, the assessment concludes that the case is **Permitted** under the HIPAA Privacy Rule for the disclosure of Medicaid patients' medical records in the context of the ongoing legal battle.